Literature DB >> 29377242

An update on cell intrinsic negative regulators of the NLRP3 inflammasome.

Barun Poudel1,2, Prajwal Gurung1,2,3,4.   

Abstract

Inflammasomes are multimeric protein complexes that promote inflammation (through specific cleavage and production of bioactive IL-1β and IL-18) and pyroptotic cell death. The central role of inflammasomes in combating infection and maintaining homeostasis has been studied extensively. Although inflammasome-mediated inflammation and cell death are vital to limit pathogenic insults and to promote wound healing/tissue regeneration, unchecked/uncontrolled inflammation, and cell death can cause cytokine storm, tissue damage, autoinflammatory and autoimmune diseases, and even death in the afflicted individuals. NLRP3 is one of the major cytosolic sensors that assemble an inflammasome. Given the adverse consequences of uncontrolled inflammasome activation, our immune system has developed tiered mechanisms to inhibit NLRP3 inflammasome activation. In this review, we highlight and discuss recent advances and our current understanding of mechanisms by which NLRP3 inflammasome can be negatively regulated. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  ASC; NLRP3; caspase-1; inflammasome; negative regulation

Year:  2018        PMID: 29377242      PMCID: PMC6202258          DOI: 10.1002/JLB.3MIR0917-350R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  114 in total

1.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

2.  INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation.

Authors:  Mohamed Lamkanfi; Geertrui Denecker; Michael Kalai; Kathleen D'hondt; Ann Meeus; Wim Declercq; Xavier Saelens; Peter Vandenabeele
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

3.  The NLRP12 inflammasome recognizes Yersinia pestis.

Authors:  Gregory I Vladimer; Dan Weng; Sara W Montminy Paquette; Sivapriya Kailasan Vanaja; Vijay A K Rathinam; Marie Hjelmseth Aune; Joseph E Conlon; Joseph J Burbage; Megan K Proulx; Qin Liu; George Reed; Joan C Mecsas; Yoichiro Iwakura; John Bertin; Jon D Goguen; Katherine A Fitzgerald; Egil Lien
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

Review 4.  A phylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins.

Authors:  K Kersse; T Vanden Berghe; M Lamkanfi; P Vandenabeele
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

5.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production.

Authors:  Tatsuya Saitoh; Naonobu Fujita; Myoung Ho Jang; Satoshi Uematsu; Bo-Gie Yang; Takashi Satoh; Hiroko Omori; Takeshi Noda; Naoki Yamamoto; Masaaki Komatsu; Keiji Tanaka; Taro Kawai; Tohru Tsujimura; Osamu Takeuchi; Tamotsu Yoshimori; Shizuo Akira
Journal:  Nature       Date:  2008-10-05       Impact factor: 49.962

Review 6.  Autoinflammatory Skin Disorders: The Inflammasomme in Focus.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2016-06-03       Impact factor: 11.951

7.  Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence.

Authors:  Olaf Gross; Hendrik Poeck; Michael Bscheider; Catherine Dostert; Nicole Hannesschläger; Stefan Endres; Gunther Hartmann; Aubry Tardivel; Edina Schweighoffer; Victor Tybulewicz; Attila Mocsai; Jürg Tschopp; Jürgen Ruland
Journal:  Nature       Date:  2009-04-01       Impact factor: 49.962

8.  NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria.

Authors:  Zhenyu Zhong; Atsushi Umemura; Elsa Sanchez-Lopez; Shuang Liang; Shabnam Shalapour; Jerry Wong; Feng He; Daniela Boassa; Guy Perkins; Syed Raza Ali; Matthew D McGeough; Mark H Ellisman; Ekihiro Seki; Asa B Gustafsson; Hal M Hoffman; Maria T Diaz-Meco; Jorge Moscat; Michael Karin
Journal:  Cell       Date:  2016-02-25       Impact factor: 41.582

9.  MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.

Authors:  Yan Zhou; Ming Lu; Ren-Hong Du; Chen Qiao; Chun-Yi Jiang; Ke-Zhong Zhang; Jian-Hua Ding; Gang Hu
Journal:  Mol Neurodegener       Date:  2016-04-16       Impact factor: 14.195

10.  Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome.

Authors:  Viola Neudecker; Moritz Haneklaus; Owen Jensen; Ludmila Khailova; Joanne C Masterson; Hazel Tye; Kathryn Biette; Paul Jedlicka; Kelley S Brodsky; Mark E Gerich; Matthias Mack; Avril A B Robertson; Matthew A Cooper; Glenn T Furuta; Charles A Dinarello; Luke A O'Neill; Holger K Eltzschig; Seth L Masters; Eóin N McNamee
Journal:  J Exp Med       Date:  2017-05-09       Impact factor: 14.307

View more
  11 in total

Review 1.  Reconciling protective and pathogenic roles of the NLRP3 inflammasome in leishmaniasis.

Authors:  Valerie Harrington; Prajwal Gurung
Journal:  Immunol Rev       Date:  2020-06-20       Impact factor: 12.988

Review 2.  Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases.

Authors:  Tomohiko Murakami; Yuri Nakaminami; Yoshifumi Takahata; Kenji Hata; Riko Nishimura
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

3.  Allergic asthma: RIPK2 takes the lead.

Authors:  Barun Poudel; Prajwal Gurung
Journal:  J Leukoc Biol       Date:  2018-08-14       Impact factor: 4.962

Review 4.  Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.

Authors:  Sahana Nagaraja; Disha Jain; Sannula Kesavardhana
Journal:  J Leukoc Biol       Date:  2021-05-31       Impact factor: 6.011

Review 5.  Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

Authors:  Pritam Thapa; Sunil P Upadhyay; William Z Suo; Vikas Singh; Prajwal Gurung; Eung Seok Lee; Ram Sharma; Mukut Sharma
Journal:  Bioorg Chem       Date:  2021-01-29       Impact factor: 5.307

6.  Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes.

Authors:  Lovro Vidmar; Ales Maver; Jelena Drulović; Juraj Sepčić; Ivana Novaković; Smiljana Ristič; Saša Šega; Borut Peterlin
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

7.  The reduction of XIAP is associated with inflammasome activation in RPE: implications for AMD pathogenesis.

Authors:  Jiangyuan Gao; Jing Z Cui; Aikun Wang; Hao Hang Rachel Chen; Alison Fong; Joanne A Matsubara
Journal:  J Neuroinflammation       Date:  2019-08-22       Impact factor: 8.322

Review 8.  The Role of Epigenetics in Autoimmune/Inflammatory Disease.

Authors:  Anna Elisa Andrea Surace; Christian M Hedrich
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

9.  Prdx4 limits caspase-1 activation and restricts inflammasome-mediated signaling by extracellular vesicles.

Authors:  Simone Lipinski; Steffen Pfeuffer; Philipp Arnold; Christian Treitz; Konrad Aden; Henriette Ebsen; Maren Falk-Paulsen; Nicolas Gisch; Antonella Fazio; Jan Kuiper; Anne Luzius; Susanne Billmann-Born; Stefan Schreiber; Gabriel Nuñez; Hans-Dietmar Beer; Till Strowig; Mohamed Lamkanfi; Andreas Tholey; Philip Rosenstiel
Journal:  EMBO J       Date:  2019-09-23       Impact factor: 11.598

10.  Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease.

Authors:  R K Subbarao Malireddi; Prajwal Gurung; Sannula Kesavardhana; Parimal Samir; Amanda Burton; Harisankeerth Mummareddy; Peter Vogel; Stephane Pelletier; Sandeepta Burgula; Thirumala-Devi Kanneganti
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.